Market Cap 148.12M
Revenue (ttm) 0.00
Net Income (ttm) -21.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.35
Volume 111,500
Avg Vol 1,162,782
Day's Range N/A - N/A
Shares Out 78.37M
Stochastic %K 45%
Beta 2.99
Analysts Hold
Price Target $3.00

Company Profile

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (908) 967-6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
TwongStocks
TwongStocks Sep. 12 at 8:27 PM
$CTXR files an amended 13D updating their ownership position in $CTOR. Ownership stake drops from 84.3% to 79.1% as a result of CTOR's offering. https://www.sec.gov/Archives/edgar/data/1506251/000121390025087227/xslSCHEDULE_13D_X01/primary_doc.xml CTXR still owns 66,049,615 shares (unchanged) CTOR now has 83,513,442 outstanding shares. CTXR owns 79.1%
0 · Reply
BALUGA825
BALUGA825 Sep. 11 at 2:49 PM
$CTOR $CTXR Lez Go ! Market is good today and probably tomorrow too. Slingshot for next week....
0 · Reply
sn0wball
sn0wball Sep. 10 at 8:39 PM
$CTOR took a weird drop monday AH, why does it do that?
1 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:15 PM
$CTOR A note regarding General Instruction IB6. Since the value of their public float is less than $75M, they are restricted in how much they can raise under General Instruction IB6 of Form S-3. As of Aug 27, public float was 12,299,741 shares. Highest price in the last 60 days was $2.71 on July 11. Value of public float is $33,332,298.11. Under IB6, the most CTOR can raise under the current shelf is 1/3rd of the public float, $11,110,766.03. They were able to register this $9M offering under the S-3 shelf. However, they are not able to register the warrants, due to the IB6 limit. Which is why the warrants will be registered under a separate S-1 filing in a concurrent private placement. S-1 filings do not have the same restrictions as S-3's.
0 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:04 PM
$CTOR CTOR files prospectus for $9M offering https://www.sec.gov/Archives/edgar/data/1851484/000121390025086384/ea0256104-424b5_citius.htm 5,142,858 Shares at $1.75, gross proceeds $9M. After fees and expenses, net proceeds expected to be $7.48M. The shares are registered pursuant to the $200M shelf filed earlier in September. CTOR's outstanding shares will be 83,513,442. Offering expected to close Sept 10. 65 day lock-up (approx Nov 14). 5,142,858 warrants will be issued in a concurrent private placement, with a $1.84 exercise price. The warrants will be registered under a separate S-1. Amendment to Promissory Note: In Aug 2024, CTOR issued a promissory note to $CTXR for $3.8M. Under the original terms, the Note had to be repaid if CTOR did a single capital raise of at least $10M. CTOR will now repay the $3.8M Note if CTOR does a series of raises that provides gross proceeds of at least $30 million. So far, CTOR raised $18M in gross proceeds. After they raise an additional $12M, they must repay CTXR. No updated cash runway in the filing.
0 · Reply
RME47pilot
RME47pilot Sep. 9 at 6:38 PM
$CTOR Smells like another pump and dump for Lenny's friends....
1 · Reply
SweStonk
SweStonk Sep. 9 at 4:02 PM
$CTOR 3 more months of nothing and another dilution. This seems to be CTXR2.0
0 · Reply
SweStonk
SweStonk Sep. 9 at 3:32 PM
$CTXR $CTOR So they just diluted but still need to raise additional capital in the future to get enough to launch lymphir. We wont see lymphir launch this year. Q4 2026 if we gonna stay on track for Mazurs real timeline 😂
1 · Reply
uebersoldat
uebersoldat Sep. 9 at 1:45 PM
$CTOR in 2045 - *We launched!* *stock now worth 2 pennies instead of $.0003* Hope y'all keep buying!
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:58 PM
Waiting for the prospectus for confirmation. After this offering, $CTOR should have 83,513,442 outstanding shares, assuming no warrant exercises. If that is correct, then $CTXR's ownership stake in CTOR will drop from 84.3% to 79.1% after this offering.
1 · Reply
Latest News on CTOR
TwongStocks
TwongStocks Sep. 12 at 8:27 PM
$CTXR files an amended 13D updating their ownership position in $CTOR. Ownership stake drops from 84.3% to 79.1% as a result of CTOR's offering. https://www.sec.gov/Archives/edgar/data/1506251/000121390025087227/xslSCHEDULE_13D_X01/primary_doc.xml CTXR still owns 66,049,615 shares (unchanged) CTOR now has 83,513,442 outstanding shares. CTXR owns 79.1%
0 · Reply
BALUGA825
BALUGA825 Sep. 11 at 2:49 PM
$CTOR $CTXR Lez Go ! Market is good today and probably tomorrow too. Slingshot for next week....
0 · Reply
sn0wball
sn0wball Sep. 10 at 8:39 PM
$CTOR took a weird drop monday AH, why does it do that?
1 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:15 PM
$CTOR A note regarding General Instruction IB6. Since the value of their public float is less than $75M, they are restricted in how much they can raise under General Instruction IB6 of Form S-3. As of Aug 27, public float was 12,299,741 shares. Highest price in the last 60 days was $2.71 on July 11. Value of public float is $33,332,298.11. Under IB6, the most CTOR can raise under the current shelf is 1/3rd of the public float, $11,110,766.03. They were able to register this $9M offering under the S-3 shelf. However, they are not able to register the warrants, due to the IB6 limit. Which is why the warrants will be registered under a separate S-1 filing in a concurrent private placement. S-1 filings do not have the same restrictions as S-3's.
0 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:04 PM
$CTOR CTOR files prospectus for $9M offering https://www.sec.gov/Archives/edgar/data/1851484/000121390025086384/ea0256104-424b5_citius.htm 5,142,858 Shares at $1.75, gross proceeds $9M. After fees and expenses, net proceeds expected to be $7.48M. The shares are registered pursuant to the $200M shelf filed earlier in September. CTOR's outstanding shares will be 83,513,442. Offering expected to close Sept 10. 65 day lock-up (approx Nov 14). 5,142,858 warrants will be issued in a concurrent private placement, with a $1.84 exercise price. The warrants will be registered under a separate S-1. Amendment to Promissory Note: In Aug 2024, CTOR issued a promissory note to $CTXR for $3.8M. Under the original terms, the Note had to be repaid if CTOR did a single capital raise of at least $10M. CTOR will now repay the $3.8M Note if CTOR does a series of raises that provides gross proceeds of at least $30 million. So far, CTOR raised $18M in gross proceeds. After they raise an additional $12M, they must repay CTXR. No updated cash runway in the filing.
0 · Reply
RME47pilot
RME47pilot Sep. 9 at 6:38 PM
$CTOR Smells like another pump and dump for Lenny's friends....
1 · Reply
SweStonk
SweStonk Sep. 9 at 4:02 PM
$CTOR 3 more months of nothing and another dilution. This seems to be CTXR2.0
0 · Reply
SweStonk
SweStonk Sep. 9 at 3:32 PM
$CTXR $CTOR So they just diluted but still need to raise additional capital in the future to get enough to launch lymphir. We wont see lymphir launch this year. Q4 2026 if we gonna stay on track for Mazurs real timeline 😂
1 · Reply
uebersoldat
uebersoldat Sep. 9 at 1:45 PM
$CTOR in 2045 - *We launched!* *stock now worth 2 pennies instead of $.0003* Hope y'all keep buying!
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:58 PM
Waiting for the prospectus for confirmation. After this offering, $CTOR should have 83,513,442 outstanding shares, assuming no warrant exercises. If that is correct, then $CTXR's ownership stake in CTOR will drop from 84.3% to 79.1% after this offering.
1 · Reply
SweStonk
SweStonk Sep. 9 at 12:40 PM
$CTOR I told ya. Dump INCOMING
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:32 PM
$CTOR $CTXR New offering for CTOR https://www.prnewswire.com/news-releases/citius-oncology-announces-pricing-of-9-0-million-registered-direct-offering-and-concurrent-private-placement-302550263.html 5,142,858 shares at $1.75 . 5,142,858 warrants at $1.84.
0 · Reply
DrKyle
DrKyle Sep. 8 at 6:24 PM
2 · Reply
irtaza5
irtaza5 Sep. 6 at 8:11 AM
2 · Reply
BALUGA825
BALUGA825 Sep. 5 at 4:54 PM
$CTOR $CTXR I dont think they will go lower than the highlighted pps.is that the warrant price ?
1 · Reply
TwongStocks
TwongStocks Sep. 5 at 10:06 AM
$CTOR SEC has filed the Notice of Effectiveness for the S-3 https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&filenum=333-289979
1 · Reply
MrPheonix
MrPheonix Sep. 4 at 9:23 PM
$CTOR watching
1 · Reply
SweStonk
SweStonk Sep. 4 at 2:23 PM
$CTXR $CTOR No money This management have had alot of oppurtunities to stop the bleeding but they have waved away every single option. It is like they want nothing except to crash the SP to oblivion. Since Mazur took over they have 1. Diluted at the possible lowest price every single time both in CTXR and CTOR. 2. Waited way to long before doing an offering. 3. Not held a single timeline. Before he took over we had more than enough to take ML to market even with hiccups. Now they are running it to bankruptcy by doing small offerings every third month suppressing the SP and destroying every single possible sign of recovery. Get rid of the management already or atleast Mazur.. CRMD had problem and retarded management, look at them now after they fired the retards.
0 · Reply
uebersoldat
uebersoldat Sep. 2 at 3:49 PM
$CTOR Dilute. Fine. Just do it so we can make some damn money Leonard.
0 · Reply
TwongStocks
TwongStocks Sep. 2 at 12:44 PM
$CTOR Correction to my phrasing here. CTOR's market cap is over $75M. They are limited by General Instruction IB6 in the S-3 because the value of shares held by non-affiliates is below $75M. Since CTXR owns 84%, the public float is less than $75M. 12,299,741 shares held by non-affiliates. When the value of the public float is over $75M, they will be able to fully utilize the $200M shelf. Not market cap.
1 · Reply
donein12
donein12 Sep. 2 at 12:35 PM
$CTOR Quote: "Since CTOR's market cap is below $75M" CTOR's market cap is $170 million. They have 78.3 million shres outstanding. For the market cap to be $75 million the price would have to be .96
0 · Reply
TwongStocks
TwongStocks Sep. 2 at 12:35 PM
$CTOR The S-3 disclosed that the 6.8m warrants from the July offering were issued to Armistice Capital. The July offering was for 6,818,182 shares and 6,818,182 warrants (not including the warrants given to Maxim). So Armistice was the sole buyer of that offering. It also disclosed that Armistice is under a 4.99% blocker limit. Which means Armistice cannot exercise warrants if it would mean they go over 4.99% ownership.
1 · Reply